fbpx
June 23, 2020

More Than a Third of Migraineurs Use Opioids for Treatment More Than a Third of Migraineurs Use Opioids for Treatment

NEW YORK (Reuters Health) – Opioids continue to be used for the treatment of migraine in the U.S., contrary to practice guidelines, according to new findings. […]
June 22, 2020

Headache Day ‘Threshold’ for Chronic Migraine Called Into Question Headache Day ‘Threshold’ for Chronic Migraine Called Into Question

People with high-frequency episodic migraine and low-frequency chronic migraine may have similar treatment needs because characteristics of the two disorders overlap significantly, calling into question the […]
June 22, 2020

FDA OKs Implantable Neurostimulator for Intractable Low Back Pain FDA OKs Implantable Neurostimulator for Intractable Low Back Pain

The US Food and Drug Administration (FDA) has approved an implantable neurostimulation system (ReActiv8, Mainstay Medical) to treat intractable chronic low back pain associated with multifidus […]
June 19, 2020

Circadian Rhythm Changes Linked to Future Parkinson’s Risk Circadian Rhythm Changes Linked to Future Parkinson’s Risk

Abnormalities in circadian rhythm may represent an important feature in the very early stages of Parkinson’s disease before symptoms develop, a new study suggests. “We found […]
June 19, 2020

NSAID/Triptan Combo Improves Treatment-Resistant Migraine NSAID/Triptan Combo Improves Treatment-Resistant Migraine

A combination of rizatriptan and the nonsteroidal anti-inflammatory drug (NSAID) meloxicam formulated to improve oral absorption led to better pain control than did rizatriptan alone in […]
June 19, 2020

Intranasal DHE Promising in Migraine Intranasal DHE Promising in Migraine

An intranasal form of dihydroergotamine (DHE) targeting the upper nasal region is safe and effective for the treatment of migraine, and ranks high in patient satisfaction, […]
June 19, 2020

CGRPs in Real World: Similar Efficacy, More AEs CGRPs in Real World: Similar Efficacy, More AEs

The calcitonin gene–related peptide receptor monoclonal antibodies (CGRP mAbs) for treatment of migraine have gained wide acceptance since their approval in 2018, but a real-world study […]
June 19, 2020

Headache May Predict Clinical Evolution of COVID-19 Headache May Predict Clinical Evolution of COVID-19

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Headache may be a key symptom of COVID-19 that predicts the disease’s […]
June 18, 2020

Adding CGRP to Botox Safe, Effective for Migraine Prevention Adding CGRP to Botox Safe, Effective for Migraine Prevention

Adjunctive preventive therapy with a calcitonin gene-related peptide monoclonal antibody (CGRP-mAb) medication is safe and effective in patients with chronic migraine who have only achieved a […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0